Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Interstitial Lung Disease · Common Variable Immunodeficiency

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Alma Andrade) · Alma.Andrade@ucsf.edu · 415-476-7054
    Contact: Principal Investigator (Michele Pham, MD)
  • University of South Florida, Tampa, Florida, United States

    Contact: Study coordinator (Jolan Walter) · jolanwalter@usf.edu · 727-553-1258
    Contact: Principal Investigator (Jolan Walter, MD)
  • Lahey Hospital and Medical Center, Burlington, Massachusetts, United States

    Contact: Study coordinator (Jocelyn Farmer, MD) · Jocelyn.Farmer@lahey.org
    Contact: Study coordinator (Ahmed Sanousi) · Ahmed.Sanousi@lahey.org
    Contact: Principal Investigator (Jocelyn Farmer, MD)
  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Dahir Sharif) · sharif.dahir@mayo.edu · 507-255-1574
    Contact: Principal Investigator (Avni Joshi, MD)
  • Duke University Health System, Durham, North Carolina, United States

    Contact: Study coordinator (Katherine Prince) · katherine.prince@duke.edu · 919-681-8931
    Contact: Principal Investigator (Peter Bressler, MD)
  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Michael Jordan) · Michael.Jordan@cchmc.org · 513-803-9063
    Contact: Principal Investigator (Michael Jordan, MD)
מובילי המחקר
  • Michael Jordan

    Principal Investigator

    Children's Hospital Medical Center, Cincinnati